Detajmium
Drug profile
Also known as: detajmium bitartrate, detajmium bitartrate hydrate, tachmalcor
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Detajmium is a drug catalogued in DrugCentral. Recorded indications include Supraventricular arrhythmia and Ventricular arrhythmia.
- Indications: Supraventricular arrhythmia and Ventricular arrhythmia.
- Molecular formula: C27H42N3O3; molecular weight 456.65 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (2)
- Supraventricular arrhythmia
- Ventricular arrhythmia
Chemical structure
| Molecular formula | C27H42N3O3 |
|---|---|
| Molecular weight | 456.65 g/mol |
| CAS number | 47719-70-0 |
| InChIKey | IXLGLCQSNUMEGQ-PYJPINIGSA-N |
| PubChem CID | 118984402 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Detajmium used for?
DrugCentral lists the following indications for Detajmium: Supraventricular arrhythmia and Ventricular arrhythmia.
What is the chemical formula of Detajmium?
Detajmium has the molecular formula C27H42N3O3 and a molecular weight of 456.65 g/mol.
Browse: all drugs starting with D · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 823 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- PubChem CID 118984402 — chemical identifiers
- FDA UNII BG60K165ZS — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.